Durect Competitors and Similar CompaniesClear all
Sucampo Pharmaceuticals's competitors and similar companies include Biofrontera and BTG.
 Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | ||
Founding Date | Founding Date 1996 | Founding Date 2012 | Founding Date 1948 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | Locations Leverkusen, DE HQ | |
Employees | Employees 37 | Employees 91 | Employees 650 |
Financial | |||
Revenue (est.) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $76m (FY, 2016) | Cost of goods €2.2m (FY, 2025) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $154.1m (FY, 2016) | Gross profit €11.2m (FY, 2025) | Gross profit £510.3m (FY, 2019) |
Net income | Net income $18.5m (FY, 2016) | Net income (€6.9m) (FY, 2025) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Biofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company